We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Sucrose and fat content significantly affects palatable food consumption in adolescent male and female rats.
Appetite 2017 November 2
Hyperpalatable foods are highly pleasurable and possess a heightened capacity to stimulate eating. Adolescents appear especially vulnerable to hyperpalatable foods. These foods are typically high in sugar, fat, or both, but the specific elements that underlie their increased consumption are still not clearly understood. Combinations of high fat and high sugar may particularly intensify overeating. Animal models allow investigation of the consumption of these foods separately from many of the environmental and psychological influences that impact eating in humans. The current study compared intakes of sucrose, fat, and a sucrose-fat combination when offered to male and female rats intermittently (2 h, three times per week for five weeks) during the vulnerable period of adolescence. Consumption of these foods, and of freely available normally nutritive lab chow was measured. Animals given the sucrose-fat food consumed significantly more than all other groups and were the only group to show significant increases in consumption during the first week. Moreover, the sucrose-fat group consumed significantly less chow than any other group. In comparison with previous reports in adult rats, adolescent rats appeared to heighten consumption of the sucrose-fat food more markedly and to show less pronounced sex differences. These data highlight the unique vulnerability and increased biological susceptibility of adolescent rats to sweet-fat food rewards and demonstrate the need to similarly investigate the preference for and the consumption of different hyperpalatable foods in human adolescents.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app